跳转至内容
Merck

SBR00065

Sigma-Aldrich

Rifampicin Ready Made Solution

50 mg/mL in DMSO

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C43H58N4O12
CAS号:
分子量:
822.94
分類程式碼代碼:
41116107
NACRES:
NA.76

形狀

liquid

品質等級

比活性

Antibacterial

濃度

50 mg/mL in DMSO

抗生素活性譜

Gram-negative bacteria
Gram-positive bacteria
mycobacteria
viruses

作用方式

protein synthesis | interferes

儲存溫度

−20°C

InChI

1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1

InChI 密鑰

JQXXHWHPUNPDRT-WLSIYKJHSA-N

一般說明

Rifampicin is a microlide antibiotic effective against gram-positive and gram-negative bacteria, mycobacteria and viruses.

應用

  • Rifampicin is used to treat Tuberculosis and Tuberculosis-related mycobacterial infections.
  • Rifampicin is widely used as an antipruritic agent in the autoimmune cholestatic liver disease, and primary biliary cirrhosis (PBC).
  • Rifampicin was also found active by inhibiting Tau Oligomer Propagation in Alzheimer’s disease.
  • Rifampicin is used as a selection agent for agrobacterium mediated plant transformation.

生化/生理作用

Inhibits the assembly of DNA and protein into mature virus particles.
Mode of Action: Inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase.

其他說明

The product is supplied in DMSO at a concentration of 50 mg/mL. Working concentrations for agrobacterium selection are typically 10-50 mg/L.

危險聲明

危險分類

Lact.

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

188.6 °F - closed cup

閃點(°C)

87 °C - closed cup


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Guidelines for the Management of Cholestatic Liver Diseases (2021)
Lu, Lungen
Journal of clinical and translational hepatology (2022)
Specific packaging of custom RNA molecules into cowpea mosaic virus-like particles
Peyret, Hadrien, et al
Methods in Molecular Biology, 103-111 (2022)
Treatment of rifampicin-resistant tuberculosis disease and infection in children: key updates, challenges and opportunities
Howell, Pauline, et al.
Pathogens (Basel, Switzerland), 11.4, 381-381 (2022)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门